SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?


To: Secret_Agent_Man who wrote (153626)2/27/2002 9:59:48 AM
From: patron_anejo_por_favor  Respond to of 436258
 
<<it's merely the active metabolite of claritin re-classified for the masses and isa no different it sux.....>>

That's all it needs to be, it'll extend the effective patent life and that's what's important to them at this point. Agree on Peg-Intron...hep C diagnoses skyrocketing nationwide (as are serious complication, cirrhosis, liver failure, etc). They'll do well with this for a long time to come (as will ICN).